Ignet

Gene Information

Gene symbol: CD300A

Gene name: CD300a molecule

HGNC ID: 19319

Synonyms: Irp60, CMRF35H, CMRF-35-H9, IRC1, IRC2, IGSF12

Related Genes

#	Gene Symbol	Number of hits
1	CD300C	1 hits
2	CD4	1 hits

Related Sentences

#	PMID	Sentence
1	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
2	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
3	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
4	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
5	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
6	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
7	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
8	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
9	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
10	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
11	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
12	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
13	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
14	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
15	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
16	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
17	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
18	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
19	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
20	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
21	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
22	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
23	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
24	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
25	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
26	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
27	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
28	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
29	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
30	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
31	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
32	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
33	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
34	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
35	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
36	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
37	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
38	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
39	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
40	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
41	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
42	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
43	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
44	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
45	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
46	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
47	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
48	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
49	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
50	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
51	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
52	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.